---

$4.60

+0.0650 ( +1.44% ) 389.4K

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-06-18	Buy	40485.00	Schall Thomas J.
2024-06-13	Sale	-33350.00	BERMAN ANN E
2024-06-13	Sale	-33350.00	CARPENTER ROBERT J
2024-06-13	Sale	-33350.00	KEATING LAURIE
2024-06-13	Sale	-8588.00	Schall Thomas J.
2024-06-13	Sale	-33350.00	Feinberg Peter
2024-06-13	Sale	-33350.00	HAUSMAN DIANA
2024-05-23	Sale	-88600.00	Neufeld Leah R
2024-05-23	Sale	-10000.00	Morales Mallory
2024-05-23	Sale	-101116.00	Bookman Michael